Published in PLoS One on November 07, 2011
Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β. Genes Immun (2014) 1.05
Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts. Clin Exp Allergy (2013) 0.88
Can we produce true tolerance in patients with food allergy? J Allergy Clin Immunol (2013) 0.86
Thrombospondin-1 (TSP1)-producing B cells restore antigen (Ag)-specific immune tolerance in an allergic environment. J Biol Chem (2015) 0.82
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05
Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (1994) 8.69
Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol (2004) 7.41
Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity (2000) 6.97
TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med (2005) 6.87
Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol (2007) 5.14
T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med (2005) 4.28
IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol (2007) 3.82
Oral tolerance. Immunol Rev (2005) 3.48
TGF-beta receptor signaling. Biochim Biophys Acta (1997) 2.99
Plasmacytoid dendritic cells mediate oral tolerance. Immunity (2008) 2.66
Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol (1991) 2.46
Immune responses to dietary antigens: oral tolerance. Immunol Today (1998) 2.04
Regulatory T cells in the periphery. Immunol Rev (2006) 1.94
Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol (2009) 1.66
Oral tolerance: therapeutic implications for autoimmune diseases. Clin Dev Immunol (2006) 1.63
Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogene (1998) 1.43
Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur J Immunol (2002) 1.40
gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses. J Exp Med (1996) 1.35
Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur J Immunol (2001) 1.33
Osteoblastic responses to TGF-beta during bone remodeling. Mol Biol Cell (1998) 1.28
Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol (2008) 1.25
Peyer's patches are required for oral tolerance to proteins. Proc Natl Acad Sci U S A (2001) 1.21
Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-beta receptors. J Biol Chem (1995) 1.13
Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol (2011) 1.11
Oral tolerance. J Clin Immunol (1998) 1.11
Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance. Gastroenterology (2009) 1.10
Functional CD25- and CD25+ mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application. Eur J Immunol (2003) 1.08
Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice. J Immunol (1998) 1.03
Antigen-specific, CD4+CD25+ regulatory T cell clones induced in Peyer's patches. Int Immunol (2003) 1.00
Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology (2008) 1.00
Oral tolerance. Am J Respir Crit Care Med (2000) 0.98
IL-10 and IL-27 producing dendritic cells capable of enhancing IL-10 production of T cells are induced in oral tolerance. Immunol Lett (2009) 0.97
The failure of oral tolerance induction is functionally coupled to the absence of T cells in Peyer's patches under germfree conditions. Immunobiology (2001) 0.97
Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses. J Immunol (2001) 0.97
Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis. Mod Rheumatol (2009) 0.96
Cyclooxygenase-2 in mucosal DC mediates induction of regulatory T cells in the intestine through suppression of IL-4. Mucosal Immunol (2009) 0.95
Vitamin A rewrites the ABCs of oral tolerance. Mucosal Immunol (2008) 0.94
Cutting edge: contributions of apoptosis and anergy to systemic T cell tolerance. J Immunol (2008) 0.94
gammadelta T cells regulate mucosally induced tolerance in a dose-dependent fashion. Int Immunol (1999) 0.94
T cell-mediated oral tolerance is intact in germ-free mice. Clin Exp Immunol (2006) 0.90
Oral tolerance in the treatment of inflammatory autoimmune diseases. Inflamm Res (1999) 0.89
Protection against autoimmunity in nonlymphopenic hosts by CD4+ CD25+ regulatory T cells is antigen-specific and requires IL-10 and TGF-beta. J Immunol (2005) 0.88
Adaptive T-cell responses regulating oral tolerance to protein antigen. Allergy (2010) 0.86
The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE). J Autoimmun (2007) 0.80
Clinical aspects of pediatric food allergy and failed oral immune tolerance. J Clin Gastroenterol (2010) 0.78
A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc Natl Acad Sci U S A (2009) 2.77
Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis. Proc Natl Acad Sci U S A (2010) 1.67
Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production. J Exp Med (2006) 1.36
Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. J Immunol (2003) 1.34
Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract. Infect Immun (2005) 1.15
Prognostic significance of NANOG and KLF4 for breast cancer. Breast Cancer (2012) 1.13
Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue. J Immunol (2003) 1.09
Role of gut-associated lymphoreticular tissues in antigen-specific intestinal IgA immunity. J Immunol (2004) 1.08
Nasal Flt3 ligand cDNA elicits CD11c+CD8+ dendritic cells for enhanced mucosal immunity. J Immunol (2004) 1.06
A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity. Vaccine (2008) 1.05
Id2-, RORgammat-, and LTbetaR-independent initiation of lymphoid organogenesis in ocular immunity. J Exp Med (2009) 1.04
Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines (2012) 1.04
Preferential use of DH reading frame 2 alters B cell development and antigen-specific antibody production. J Immunol (2008) 1.04
A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies. J Infect Dis (2002) 1.03
Inside the mucosal immune system. PLoS Biol (2012) 1.03
T helper type-2 cells induce ileal villus atrophy, goblet cell metaplasia, and wasting disease in T cell-deficient mice. Gastroenterology (2003) 1.02
Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-kappaB translocation. Eur J Immunol (2003) 1.01
Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology (2008) 1.00
Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae. J Immunol (2010) 0.99
Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine (2011) 0.99
Attenuation of inducible respiratory immune responses by oseltamivir treatment in mice infected with influenza A virus. Microbes Infect (2010) 0.99
Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens. J Immunol (2006) 0.97
A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration. J Immunol (2008) 0.97
Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1. J Immunol (2008) 0.97
MicroRNA profiling of gastric cancer patients from formalin-fixed paraffin-embedded samples. Oncol Lett (2011) 0.96
Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease. J Gene Med (2007) 0.96
Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit. J Immunol (2003) 0.96
A second generation of double mutant cholera toxin adjuvants: enhanced immunity without intracellular trafficking. J Immunol (2006) 0.96
A novel neurotoxoid vaccine prevents mucosal botulism. J Immunol (2005) 0.95
A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates. J Immunol (2004) 0.91
A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging. Vaccine (2011) 0.91
Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A. J Immunol (2006) 0.91
Nasal cholera toxin elicits IL-5 and IL-5 receptor alpha-chain expressing B-1a B cells for innate mucosal IgA antibody responses. J Immunol (2007) 0.89
Lack of oral tolerance in aging is due to sequential loss of Peyer's patch cell interactions. Int Immunol (2003) 0.89
A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice. J Immunol (2011) 0.88
Type 1 and 2 T helper cell-mediated colitis. Curr Opin Gastroenterol (2006) 0.88
The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia. Infect Immun (2011) 0.88
Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media. Infect Immun (2013) 0.86
Oral-nasopharyngeal dendritic cells mediate T cell-independent IgA class switching on B-1 B cells. PLoS One (2011) 0.84
Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity. Vaccine (2009) 0.84
Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines. Expert Rev Vaccines (2009) 0.84
Co-administration of cholera toxin and apple polyphenol extract as a novel and safe mucosal adjuvant strategy. Vaccine (2009) 0.83
CD4+CD45RBHi interleukin-4 defective T cells elicit antral gastritis and duodenitis. Am J Pathol (2004) 0.82
Pathological role of large intestinal IL-12p40 for the induction of Th2-type allergic diarrhea. Am J Pathol (2004) 0.82
Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine. Vaccine (2007) 0.82
Porphyromonas gingivalis accelerates atherosclerosis in C57BL/6 mice fed a high-fat diet. Immunopharmacol Immunotoxicol (2011) 0.82
Establishment and characterization of a novel xenograft model of human gastrointestinal stromal tumor in mice. Anticancer Res (2013) 0.81
Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide. Infect Immun (2009) 0.80
Mucosal Immunosenescence in the Gastrointestinal Tract: A Mini-Review. Gerontology (2014) 0.80
A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy. Virol J (2014) 0.80
Therapeutic manipulation of the immune system: enhancement of innate and adaptive mucosal immunity. Curr Pharm Des (2003) 0.79
Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity. Mol Oral Microbiol (2010) 0.79
Expression of GLUT-1 and GLUT-3 in xanthogranulomatous cholecystitis induced a positive result on ¹⁸F-FDG PET: report of a case. Int Surg (2013) 0.79
Potential roles of CCR5(+) CCR6(+) dendritic cells induced by nasal ovalbumin plus Flt3 ligand expressing adenovirus for mucosal IgA responses. PLoS One (2013) 0.77
Development of an enzyme-free glucose sensor using the gate effect of a molecularly imprinted polymer. J Artif Organs (2009) 0.76
Expression analysis of iPS cell - inductive genes in esophageal squamous cell carcinoma by tissue microarray. Anticancer Res (2012) 0.76
Mucosal regulatory cells in the gastrointestinal tract and periodontium. Periodontol 2000 (2010) 0.76
Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity. FEMS Immunol Med Microbiol (2012) 0.76
Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice. J Oral Sci (2013) 0.76
Nasal IL-12p70 DNA prevents and treats intestinal allergic diarrhea. J Immunol (2005) 0.76
Notch-ligand expression by NALT dendritic cells regulates mucosal Th1- and Th2-type responses. Biochem Biophys Res Commun (2011) 0.76
Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination. Vaccine (2011) 0.76
Elicitation of mucosal immunity by proteins of Streptococcus pneumoniae. Adv Otorhinolaryngol (2011) 0.75
Midazolam inhibits IgE production in mice via suppression of class switch recombination. J Oral Sci (2014) 0.75